Patients with lung adenocarcinoma have a high rate of positive EGFR mutations, especially in Asian, nonsmoking, and female populations, where the mutation rate of EGFR is as high as 40%–50%.23 The gene discussed is EGFR; the disease is lung adenocarcinoma.